| Literature DB >> 32834559 |
Maria Cristina Collivignarelli1,2, Carlo Collivignarelli3, Marco Carnevale Miino1, Alessandro Abbà3, Roberta Pedrazzani4, Giorgio Bertanza3.
Abstract
As for the SARS coronavirus in the 2003 epidemic, the presence of SARS-CoV-2 has been demonstrated in faeces and, in some cases, urine of infected people, as well as in wastewater. This paper proposes a critical review of the state of the art regarding studies on the presence of SARS-CoV-2 in wastewater and sewage sludge, the factors affecting its inactivation and the main proposed treatments. In-vitro tests demonstrated low resistance of SARS-CoV-2 to high temperature, while even significant changes in pH would not seem to determine the disappearance of the virus. In real wastewater and in sewage sludge, to date studies on the influence of the different parameters on the inactivation of SARS-CoV-2 are not available. Therefore, studies involving other HCoVs such as SARS-CoV and HCoV-229E have been also considered, in order to formulate a hypothesis regarding its behaviour in sewage and throughout the steps of biological treatments in WWTPs. Finally, SARS-CoV-2 in wastewater might track the epidemic trends: although being extremely promising, an effective and wide application of this approach requires a deeper knowledge of the amounts of viruses excreted through the faeces and the actual detectability of viral RNA in sewage.Entities:
Keywords: CoViD; Coronavirus removal; Human health; SARS; Sewage sludge; Wastewater
Year: 2020 PMID: 32834559 PMCID: PMC7334965 DOI: 10.1016/j.psep.2020.06.049
Source DB: PubMed Journal: Process Saf Environ Prot ISSN: 0957-5820 Impact factor: 6.158
Literature results on presence of SARS-CoV-2 in faeces and urine.
| References | Number of tested patients | Tested samples | Main findings | |
|---|---|---|---|---|
| Faeces | Urine | |||
| 153 | ● | N.T. | From 153 patients (68 % male) with COVID-19, faeces show positivity in 44 cases (29 %). Ct value of faeces excreted by patients was higher than 30 (< 2.6 × 104 copies/mL) | |
| 10 | ● | N.T. | Viral shedding from the digestive system might be greater and last longer than that from the respiratory tract. Ct value of faeces excreted by patients was in the range 22−40 | |
| 73 | ● | ● | Faeces and urine were tested positive. The test result for SARS-CoV-2 RNA remained positive in faeces, even after test results for the respiratory tract converted to negative. Potential faecal-oral transmission can last even after viral clearance in the respiratory tract | |
| 55 (faeces) | ● | ● | The positivity of urine samples was low with only 4 positive results (6.9 %), viral RNA in urine samples from 3 patients remained tested positive after throat swabs turned negative. In 43 cases (78.2 %) had longer duration for faeces specimens detected negative for viral RNA than throat swabs, with median delay of 2.0 days | |
| 58 (urine) | ||||
| 10 | ● | ● | There were positive SARS-CoV-2 RNA signals in all faeces specimens (100 %) but negative in all urine specimens (0%). The assessment of both faecal and respiratory specimen is recommended | |
| 9 | ● | ● | Relatively low detection rate for virus in the faeces (3 of 9 patients). The Authors suggested further investigation | |
| 6 | ● | ● | Urine from 100 % of patient were tested negative. 83 % of faeces analysed showed the presence of the virus. In 50 % of cases the duration of virus shedding in faeces was higher than 20 days | |
| 1 | ● | ● | Ct value of faeces excreted by patient on illness day 7 was in the range 36−38. Urine was tested negative | |
| 5 | ● | ● | No urine samples were tested positive. In 40 % of patients, SARS-CoV-2 RNA was detected in the faeces up to 19 days after onset symptoms | |
| 23 | ● | ● | All urine samples were negative except for two severe cases. The median duration of virus shedding was 22 d for the faeces (with peak of 26 d), more than double with respect to nasal-throat mixed swabs (10 d) | |
| 2 | ● | ● | In urine and faeces no SARS-CoV-2 RNA was detected | |
| 17 | ● | n.a. | No in urine and faeces. In 53 % of samples SARS-CoV-2 RNA was found. Viral loads range from 550 copies mL−1 to 1.21 × 10⁵ copies mL−1 | |
| 42 | ● | N.T. | More than 65 % of patients were tested positive for SARS-CoV-2 RNA in faeces. After the pharyngeal swabs turned negative, the faeces of 18 patients remained positive (virus shedding equals to 6–10 d) | |
N.T.: not tested; n.a.: not available.
Literature results on presence of SARS-CoV-2 in untreated wastewater.
| References | Location | Number of points examined | Period of examination | Samples Positive (total number of samples) | Ct value |
|---|---|---|---|---|---|
| Israel | 17 | 10/03/2010−21/04/2020 | 10 (26) | 32.76−38.5 | |
| U.S.A. (Massachusetts) | 2 | 08/01/2020−25/03/2020 | 10 (12) | 33.87−38.39 | |
| Italy | 3 | 14/04/2020−22/04/2020 | 4 (12) | n.a. | |
| Australia | 3 | 20/03/2020−01/04/2020 | 2 (9) | 37.5−39a | |
| Netherlands | 7 | 05/02/2020−16/03/2020 | 14 (24) | n.a. | |
| Spain | 3 | 12/02/2020−14/04/2020 | 13 (15) | 34.00–37.84 | |
| Spain | 6 | 12/03/2020−14/04/2020 | 37 (72) | 34.00–40.00 | |
| France | 3 | 05/03/2020−23/04/2020 | 100 % of samples positiveb | n.a. | |
| Italy | 4 | 03/02/2020−02/04/2020 | 6 (12) | n.a. | |
| Turkey | 9 | 21/04/2020−25/04/2020 | 7 (9) | 34.67−39.54 a | |
| India | 1 | 08/05/2020−27/05/2020 | 2 (2) | 32.65−39.56 | |
| India | 8 | 04/05/2020−12/06/2020 | 6 (17) | 5.19–37.52 | |
| Spain | 1 | 06/04/2020−21/04/2020 | 7 (7) | 33.61−39.60 | |
| Japan | 1 | 17/03/2020−07/05/2020 | 0 (5) | n.a. | |
| U.S.A. (New York) | 11 | 06/05/2020 – 13/05/2020 | 18 (22) | n.a. |
n.a.: not available.
aExpressed as Cq.
bTotal number of samples not available.
Fig. 1Proposed scheme for monitoring the infection status of urban areas.